Myson Business Summary

Myson Century, Inc. (5314.TWO) is a Taiwan-based fabless semiconductor company that has evolved into a diversified holding group following a 2021 management takeover by Sun Yad Construction. The company generates revenue through a multi-sector model encompassing its legacy integrated circuit (IC) design business, biotechnology, catering, and construction materials trading. Its primary technology segments focus on microcontroller units (MCUs) for automotive electronics, liquid crystal displays (LCDs), and communication ICs, while its high-growth Chaohe Biomedical division specializes in health supplements, notably pioneering food-grade exosome technology. Myson operates in a competitive landscape alongside semiconductor peers such as MediaTek, Leadtrend Technology, and Silicon Integrated Systems, distinguishing itself through a strategic pivot toward consumer-facing health and lifestyle markets to offset the cyclicality of the electronics industry. The company is currently led by Chairman Zhang Youming (Chang Yu-Ming) and General Manager Shuo-Wen Chang, both of whom represent the interests of the parent entity, Sun Yad Construction Co., Ltd. This leadership team has overseen the firm's aggressive diversification strategy, leveraging their background in construction and real estate to expand into decoration projects and smart robot modules for industrial applications. Major institutional backing is provided by Sun Yad Construction, which holds a controlling interest, alongside significant stakes from Kin Hung Co., Ltd. and Hsinli Chemical Industrial Corp. The board, recently re-elected in 2024 and confirmed for the 2026 annual general meeting, includes key directors such as Tseng Pong-Kuang, maintaining a focus on integrating traditional IC expertise with emerging biotechnology and e-commerce retail channels.